Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?

Introduction: Globally, there is a considerable burden of HCV and HIV infections among people who inject drugs (PWID) and transmission of both infections continues. Needle and syringe programme (NSP) and opioid substitution therapy (OST) coverage remains low, despite evidence demonstrating their pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Grebely, Jason, Dore, Gregory J., Morin, Sébastien, Rockstroh, Jürgen K., Klein, Marina B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577699/
https://www.ncbi.nlm.nih.gov/pubmed/28782335
http://dx.doi.org/10.7448/IAS.20.1.22146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577699/
https://www.ncbi.nlm.nih.gov/pubmed/28782335
http://dx.doi.org/10.7448/IAS.20.1.22146

Ejemplares similares